Statements of Condensed Consolidated Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net losses	$ (20,644)	$ (47,006)
Less: Net losses from discontinued operations, net of tax	(735)	(802)
Net losses from continuing operations	(19,909)	(46,204)
Adjustments to reconcile net losses to net cash (used in)/provided by operating activities:
Depreciation and amortization	12,119	11,478
Amortization of finance costs	1,481	2,018
Impairment of property, plant and equipment	0	35,680
Undistributed earnings of unconsolidated companies	738	857
Tax on earnings of unconsolidated companies	(325)	(230)
Share-based compensation	791	1,550
Excess share-based compensation tax benefit	(96)	0
Loss/(gain) on derivatives	(143)	1,211
Change in provisions for uncertain tax positions	19	(3,921)
Change in deferred income tax	(14,731)	(11,462)
Loss on extinguishment of debt	14,506	0
Gain on disposal of property, plant and equipment	(3,704)	0
Effect of exchange rates on net losses	(3,430)	(3,355)
Change in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(440)	(4,201)
Due from unconsolidated companies	606	1,540
Prepaid expense and other	(3,344)	(1,641)
Inventories	(68)	135
Escrow and prepaid customer deposits	(1,584)	(1,047)
Accounts payable	(3,889)	(5,248)
Accrued liabilities	1,449	2,603
Deferred revenue	14,774	14,998
Other, net	94	(1,354)
Other cash movements:
Dividends from equity method investees	810	651
Payment of key money	(3,000)	0
Payment of swap termination costs	(3,985)	0
Net cash used in operating activities from continuing operations	(11,261)	(5,942)
Net cash used in operating activities from discontinued operations	(735)	(1,149)
Net cash used in operating activities	(11,996)	(7,091)
Cash flows from investing activities:
Capital expenditures	(17,998)	(20,685)
Investments in unconsolidated companies	(318)	(990)
Release of restricted cash	6,883	219
Proceeds from sale of property, plant and equipment	37,842	0
Proceeds from insurance settlements	200	65
Net cash provided by/(used in) investing activities from continuing operations	26,609	(21,391)
Net cash provided by investing activities from discontinued operations	0	18,964
Net cash provided by/(used in) investing activities	26,609	(2,427)
Cash flows from financing activities:
Proceeds from working capital loans	(133)	382
Exercised stock options and vested share awards	1	1
Excess share-based compensation tax benefit	96	0
Issuance of long-term debt	569,097	6,398
Debt issuance costs	(12,931)	(635)
Principal payments under long-term debt	(559,975)	(10,300)
Net cash used in financing activities from continuing operations	(3,845)	(4,154)
Net cash provided by/(used in) financing activities from discontinued operations	0	0
Net cash used in financing activities	(3,845)	(4,154)
Effect of exchange rate changes on cash and cash equivalents	37	(367)
Net increase/(decrease) in cash and cash equivalents	10,805	(14,039)
Cash and cash equivalents at beginning of period (includes $394 and $538 of cash presented within assets held for sale)	123,159
Cash and cash equivalents at end of period (includes $Nil and $506 of cash presented within assets held for sale)	$ 134,358